We are a digital health company revolutionising dermatology by introducing standardisation and objectivity in the process of skin imaging and assessment by our mobile medical device system Scarletred®Vision
Our product Scarletred®Vision is designed to objectify dermatology. Our product is easy to use and allows you to develop better skin care products and health care services faster at significant lower cost.
Certified and secure technology. Patented world wide
Applications
Scarletred®Vision can be used in any of the 3.000 skin disease, primarily at present in drug trials, cosmetics studies and medical routine in …
Our clients
Our award winning technology is supplied internationally to biopharma, cosmetics companies, hospitals, insurances, CRO's and medical experts.
Biopharma
Cosmetic
Hospitals
Experts
Immediate benefits
Saving costs
Working with Scarletred®Vision is very cost efficient. Automation of time and error pronce process steps lead to 90% cost reduction
Real time
We enable remote monitoring and analysis which leads to two times higher patient compliance.
Objective data
Standardization of skin imagining and scoring with Scarletred®Vision leads to superior data quality.
Certified
Scarletred®Vision is CE class I registered mobile medical device
Scope
Scarletred®Vision can be used in a broad range of dermatological applications
User-friendly
Our products are very easy to use
Hardware independent
Subscription ensures that your tools are up to date and reduces your infrastructure cost
Automation
QR and trial codes increase data safety and automate data allocation
Mobile
The system is 100% mobile
Stadt Wien zündet den 5G Turbo: 20 Mio. Euro für raschen Ausbau
Wien (OTS) - Videokonferenzen, Home Schooling, Online-Yogastunden – die aktuelle Corona-Situation hat eindrücklich bewiesen, wie wichtig digitale Kommunikation für alle Lebensbereiche geworden ist. Digital-Stadtrat Peter Hanke hat daher als Ziel vorgegeben: „Wien soll die erste Stadt Europas mit einem flächendeckenden 5G-Netz werden.“ Mit einem 20 Millionen Euro starken Fö...
Modern telemedicine for suspected corona cases: SeneCura uses the Scarletred app "eCOVID19"
SeneCura is currently using the CE-certified medical device in eleven care facilities, after which a roll-out to all SeneCura facilities in Austria is planned
Moderne Telemedizin für Corona Verdachtsfälle: SeneCura nutzt die Scarletred App „eCOVID19“
SeneCura nutzt das CE-zertifizierte Medizinprodukt derzeit in elf Pflegeeinrichtungen, danach ist ein Roll-out auf alle SeneCura Einrichtungen in Österreich geplant.
Positive ISO13485 Surveillance Audit
SCARLETRED is announcing the positive outcome of our first surveillance audit of our ISO1345 certified quality management system. The audit was conducted at 16. April 2020 by the notified body SIQ via fully digital procedures.
Let's get started
Our flexible SaaS model enables easy up-, and down scaling according to your demands.
Find out more via one of these four steps.
